Neurocentrx

Neurocentrx develops drugs for the treatment of neurological disorders. Its design areas include psychiatry, mental health and mood disorders, neurodegenerative diseases, and complex pain management in cancer and palliative care. The focus is on providing patients with existing approved drugs in new and improved forms through reformulation, repositioning, clinical development, and product licensing.